AHR suppresses cisplatin-induced apoptosis in ovarian cancer cells by regulating XIAP
- 19 November 2024
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 231, 116640
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- The complex biology of aryl hydrocarbon receptor activation in cancer and beyondBiochemical Pharmacology, 2023
- miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genesBiochemical Pharmacology, 2019
- The diverse and important contributions of the AHR to cancer and cancer immunityCurrent Opinion in Toxicology, 2017
- Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cellsCancer Letters, 2016
- Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectivesTumor Biology, 2015
- MicroRNAs in cancer biology and therapy: Current status and perspectivesGenes & Diseases, 2014
- FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activityFEBS Letters, 2014
- An endogenous aryl hydrocarbon receptor ligand inhibits proliferation and migration of human ovarian cancer cellsCancer Letters, 2013
- A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?Cell, 2011
- Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: A tumor promoting event?Biochemical Pharmacology, 2009